Xapavir 50 mg Tablets – Dolutegravir 50 mg for HIV Treatment in India

Xapavir 50 mg Tablets contain dolutegravir 50 mg, an antiretroviral medicine used as part of HIV treatment. Dolutegravir belongs to the integrase strand transfer inhibitor class and works by interfering with the ability of HIV to integrate its genetic material into human cells. It is generally used in combination with other antiretroviral medicines according to an individual’s prescribed treatment regimen. Indian HIV treatment guidance includes dolutegravir-based regimens for appropriate patients.

Xapavir 50 mg Tablets Uses

Xapavir 50 mg Tablets are used in the management of HIV-1 infection as part of combination antiretroviral therapy. Treatment aims to reduce the amount of HIV in the body, support immune function and maintain viral suppression when taken consistently as prescribed.

Dolutegravir-based treatment is also reflected in current international HIV recommendations. In its updated 2025 clinical management recommendations, the World Health Organization continues to support dolutegravir-based regimens for initial and subsequent HIV treatment.

How Xapavir 50 mg Works

The active ingredient, dolutegravir, blocks the HIV integrase enzyme. This enzyme is required for HIV to insert its genetic material into human cells. By inhibiting integrase, dolutegravir helps prevent HIV from completing an important stage of its replication cycle.

Because HIV treatment normally requires a combination of antiretroviral medicines, Xapavir should be taken only as part of the regimen prescribed by a qualified healthcare professional.

Xapavir 50 mg Dosage and Administration

The appropriate dose and treatment schedule depend on the patient's age, medical history, other medicines being taken and the prescribed HIV treatment regimen. Do not change the dose, stop treatment or take additional tablets without medical advice.

Take the tablet exactly as directed. Consistent treatment is important because missed doses can affect treatment effectiveness and may contribute to the development of drug resistance.

Possible Side Effects

Some people taking dolutegravir may experience side effects such as headache, nausea, diarrhoea, dizziness or tiredness. Side effects can vary between individuals and may depend on the complete antiretroviral regimen.

Seek medical attention if you experience severe, persistent or unusual symptoms. Your healthcare professional can determine whether symptoms are related to dolutegravir or another medicine in the treatment regimen.

Important Precautions

Tell your doctor about all medicines, supplements and health conditions before starting treatment. Certain medicines can interact with dolutegravir and may require changes in timing, dosage or treatment selection.

Patients should also inform their healthcare professional if they have a history of liver or kidney problems. Medical monitoring may be recommended during HIV treatment based on individual circumstances.

Xapavir 50 mg Tablets in India

For patients and healthcare providers in India, sourcing prescription medicines should be carried out through licensed pharmacies, authorised distributors or legally compliant pharmaceutical suppliers. Product availability, prescription requirements, packaging and applicable pricing may vary by location.

If you are looking for Xapavir 50 mg Tablets in India, verify the product strength, packaging and source before purchase. A valid prescription and professional medical guidance should be followed for HIV treatment.

Frequently Asked Questions

What is Xapavir 50 mg?

Xapavir 50 mg contains dolutegravir 50 mg and is used as part of combination antiretroviral therapy for HIV.

What is Xapavir 50 mg used for?

It is used in the treatment and management of HIV-1 infection as part of an appropriate antiretroviral regimen.

Can Xapavir 50 mg be taken without a prescription?

HIV treatment should be started and managed under the supervision of a qualified healthcare professional.

Should Xapavir 50 mg be stopped when I feel better?

No. HIV treatment should not be stopped or changed without consulting the treating healthcare professional.